CNBC: The Case for Legalizing and Investing in Psychedelics

CNBC: The Case for Legalizing and Investing in Psychedelics

Press
Jun 8
/

Psychedelic therapy company Field Trip Health is looking to go public on the Nasdaq. Executive chair and co-founder Ronan Levy and former Senate Majority Leader Tom Daschle join ‘Squawk on the Street’ to make the case for investing in these therapies, the drugs involved and more.

Other posts
See all posts
No items found.